As our healthcare system has evolved to provide higher quality care to more — and increasingly clinically complicated — people, the disconnect between what’s billed, what’s documented, and what’s actually true has deepened. The post Payment Integrity is a Systems Problem, not a Data Glitch appeared first on MedCity News.
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to…
Get Accurate Results with Blood Test at Home You need not wait several days for a doctor’s appointment or spend hours waiting at diagnostic labs. These modern test kits allow you to monitor important health markers right from your home, with accurate results delivered quickly and privately. Whether you’re keeping an eye on your cholesterol,…
Beam Therapeutics’ first clinical data in the rare disease alpha-1 antitrypsin deficiency “set a bar for efficacy in the space,” according to one analyst. But the ongoing market slide poses challenges for biotech companies aiming to raise money by selling stock. The post Beam Base Editor’s Early Data in Rare Liver Disease Tee Up $500M…
While worries about the affordability of care are sure to persist for many Americans over the coming year, here are some other patient payment trends for providers to watch The post 2025 Trends to Watch in Patient Payments appeared first on MedCity News.
Ampreloxetine’s Phase 3 failure in multiple system atrophy is the third disappointing clinical trial outcome for the Theravance Biopharma drug. The biotech will now wind down all R&D and explore options that could include the sale of the company. The post Theravance Drug Fails Another Pivotal Test, This Time Sparking Restructuring That Ends R&D appeared…
A new Business Group on Health survey found that while many employers currently cover GLP-1s for weight management, rising costs are prompting some to reconsider that coverage and adopt strategies to control spending. The post About 67% of Employers Cover GLP-1s for Weight Management; That Could Decline in 2027 appeared first on MedCity News.
Analysis finds that the Audit, Risk, and Compliance Committee has not reviewed relevant oversight findings, such as from medical investigations, and has not provided recommendations for system-wide improvements
On a recent weekday evening, Ashly Richards helped her 13-year-old son, Case, with homework. He did math problems and some reading, underscoring how much he’s accomplished at his school for children with autism. Richards has heard Trump administration officials suggest that food dyes and pediatric vaccines cause autism and ADHD. That stance, she said, unfairly…
By MICHAEL MILLENSON Shared decision-making between doctors and patients may be “the pinnacle of patient-centered care,” but three new medical journal articles suggest it’s encountering more problems than peaks. Yet counterintuitively, it may be artificial intelligence that rescues this intimately human interaction. “Shared decision-making is at a crossroads,” declares a Perspective in the Journal of General…